Chronic hepatitis C infection: Protein plasma levels predict efficacy of treatments
Wednesday, January 5, 2011 - 11:32
in Health & Medicine
Scientists in France have performed biomarker discovery on patients being treated for chronic hepatitis C infection. Their work demonstrates that the plasma levels of the protein IP-10 predict, prior to treatment initiation, the efficacy of treatment with pegylated-interferon and ribavirin. Based on these results, the scientists have developed a prognostic test. Commercialization is anticipated in 2011.